• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ELI LILLY AND COMPANY HUMAPEN SAVVIO 3ML (GRAY); FOR TREATMENT PURPOSES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ELI LILLY AND COMPANY HUMAPEN SAVVIO 3ML (GRAY); FOR TREATMENT PURPOSES Back to Search Results
Model Number MS9699
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem Hyperglycemia (1905)
Event Type  Injury  
Manufacturer Narrative
New updated and corrected information is referenced within the update statements in describe event or problem.No further follow up is planned.Evaluation summary: a female patient that her humapen savvio device was not working properly and she was unable to inject insulin.The patient experienced hyperglycemia.The device was not returned to the manufacturer for investigation (batch 1402v07, manufactured february 2014).Therefore, it could not be evaluated to confirm the complaint or presence of a malfunction.Malfunction unknown.A complaint history review of the batch did not identify any atypical findings with respect to device not working issues.All humapen savvio devices are assessed for injection screw travel at the end of the manufacturing process, thus ensuring device functionality with high probability.There is no evidence of improper use or storage.
 
Event Description
(b)(4).This spontaneous case, reported by a pharmacist who contacted the company to report an adverse event, concerned a (b)(6) female patient of unknown ethnicity.Medical history and concomitant medications were not provided.The patient received an unspecified insulin via humapen savio (a reusable pen device), beginning on unknown date.Dosing regimen, indication and route of administration were not provided.On an unknown date, while using the humapen savio, she was unable to inject insulin to herself due to humapen savio pen not working properly; she was hospitalized with hyperglycemia ((b)(4), lot no not provided).She was now out of hospital and she was recovered from hyperglycemia.This was the second or third time he had problem with the humapen savio pen.Information regarding corrective treatment, outcome of drug dose omission, unspecified insulin status and status of humapen savvio device treatment was not provided.The operator of the humapen savio and training status was not provided.The humapen savio model duration of use and suspect humapen savio duration were not reported.The status of the humapen savio was not reported and its return was not provided.The reporting pharmacist related the events with humapen savio device.Edit 21mar2018: updated medwatch and european and canadian (eu/ca) fields for expedited device reporting.No new information added.Edit 22-mar-2018: upon review, added pc number to the case and narrative.Update 22mar2018: additional information received on 22mar20187 from global product complaint database.Reiterated the suspect as humapen savvio unknown color as suspect device type as the suspect device was not returned to the manufacturer.Changed the lot number from unknown to c433694 (as reported) for (b)(4) relating to the humapen savvio (unknown color).Corresponding fields and narrative updated accordingly.Update 22mar2018: additional information received on 22mar2018 from global product complaint database.Recoded the suspect humapen savvio unknown color to a humapen savvio gray.Changed the lot number from c433694 to 1402v07 for product complaint 4300716 relating to the humapen savvio gray.Corresponding fields and narrative updated accordingly.Update 30mar2018: additional information received on 29mar2018 from the global product complaint database.Entered device specific safety summary (dsss); updated the medwatch and european and canadian (eu/ca) device fields; and added the date of manufacturer for the suspect device associated with (b)(4).Corresponding fields and narrative updated accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HUMAPEN SAVVIO 3ML (GRAY)
Type of Device
FOR TREATMENT PURPOSES
Manufacturer (Section D)
ELI LILLY AND COMPANY
lilly corporate center
indianapolis IN 46285
Manufacturer (Section G)
ELI LILLY AND COMPANY
lilly corporate center
indianapolis IN 46285
Manufacturer Contact
chris davis
lilly corporate center
indianapolis, IN 46285
3174334585
MDR Report Key7422779
MDR Text Key105263799
Report Number1819470-2018-00043
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
PMA/PMN Number
K160668
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial
Report Date 04/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberMS9699
Device Lot Number1402V07
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/13/2018
Initial Date FDA Received04/11/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/28/2014
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age73 YR
-
-